COO
Improved Pharma
Dr. Pamela Smith is Chief Operating Officer for Improved Pharma, a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Improved Pharma provides fee-for-service work in areas such as solid-state screening, formulation development, analytical characterization, synchrotron testing, and patent litigation support. Current research is focused on the characterization of amorphous dispersions via synchrotron pair distribution function analysis.
Prior to joining Improved Pharma in 2018, Pamela was with SSCI for 19 years. She joined SSCI as a Research Scientist, ultimately becoming the General Manager in 2011. In 2015, she led the due diligence team resulting in the sale of SSCI to AMRI.
Pamela is a graduate of Illinois Wesleyan University (BA, Chemistry) and an alumnus of Miami University (Ph.D. Analytical Chemistry), as well as an ISSSP certified Lean Six Sigma Black Belt. She also serves as the president of the Public Schools Foundation of Tippecanoe County. Her most notable award was received in 2016 when she was recognized by the White House as a Changemaker at the inaugural United State of Women Summit in Washington DC. The summit “celebrated extraordinary women who are creating change and growth in our world – women who are doing great things.”